Your institution may have access to this item. Find your institution then sign in to continue.
Title
Definitive results of a phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinoma.
Authors
Reni, M; Passoni, P; Panucci, M G; Nicoletti, R; Galli, L; Balzano, G; Zerbi, A; Di Carlo, V; Villa, E
Abstract
To evaluate the efficacy and toxicity of a cisplatin, epirubicin, gemcitabine, and fluorouracil (PEF-G) schedule on stage IV pancreatic adenocarcinoma.
Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Vol 19, Issue 10, p2679